100A

Establishment and membership of the Pharmaceutical Benefits Advisory Committee

Current

(1)

There is to be a Committee called the Pharmaceutical Benefits Advisory Committee.

(2)

The Committee is to consist of the Chairperson and at least 11, but not more than 20, other members.

Note:

One of the members of the Committee (other than the Chairperson) may be appointed as the Deputy Chairperson of the Committee: see subsection 100B(1D).

(3)

Members forming at least 2/3 of the total membership of the Committee are to be selected from the following:

(aa)

industry;

(a)

consumers;

(b)

health economists;

(c)

practising community pharmacists;

(d)

general practitioners;

(e)

clinical pharmacologists;

(f)

specialists;

with at least one member selected from each of the interests or professions mentioned in paragraphs (a) to (f).

(4)

The remaining members (if any) of the Committee are to be persons whom the Minister is satisfied have qualifications or experience:

(a)

in a field relevant to the functions of the Committee; and

(b)

that would enable them to contribute meaningfully to the deliberations of the Committee.

(5)

The Chairperson is a member of the Committee.

This Act’s bill:Second reading speech

Research tools for this sectionSubscription

Cited by Analyse Interrogate History Equivalents

The statute text is free to read above. View subscription options to unlock the case-law research tools for each provision.